On the scientific and ethical issues of fetal somatic gene therapy
- 22 May 2002
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 9 (11) , 670-673
- https://doi.org/10.1038/sj.gt.3301761
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 13 references indexed in Scilit:
- Sustained delivery of therapeutic concentrations of human clotting factor IX - a comparison of adenoviral and AAV vectors administeredin uteroThe Journal of Gene Medicine, 2002
- In UteroGene Delivery by Intraamniotic Injection of a Retroviral Vector Producer Cell Line in a Nonhuman Primate ModelHuman Gene Therapy, 2001
- Rhesus Monkey Model for Fetal Gene Transfer: Studies with Retroviral- Based Vector SystemsMolecular Therapy, 2001
- Fetal Somatic Gene Therapy — A Preventive Approach to the Treatment of Genetic Disease: The Case ForPublished by Springer Nature ,2001
- Gene Transfer into the Fetal Primate: Evidence for the Secretion of Transgene ProductMolecular Therapy, 2000
- Successful expression of β-galactosidase and factor IX transgenes in fetal and neonatal sheep after ultrasound-guided percutaneous adenovirus vector administration into the umbilical veinGene Therapy, 1999
- In UteroGene Therapy: Transfer and Long-Term Expression of the BacterialneorGene in Sheep after Direct Injection of Retroviral Vectors into Preimmune FetusesHuman Gene Therapy, 1998
- Foetal gene delivery in mice by intra-amniotic administration of retroviral producer cells and adenovirusGene Therapy, 1997
- Human Fetal Gene Therapy: Moral and Ethical QuestionsHuman Gene Therapy, 1996
- The challenge of fetal gene therapyNature Medicine, 1995